Temple will own 60 percent of the hospital, and its partners Meadowbrook, Pa.-based Redeemer Health and the Philadelphia College of Osteopathic Medicine will split the rest. The consortium could pay an additional $4 million to Tower Health for transition services.
Under the terms of the agreement, the consortium will take over the 148-bed hospital on Jan. 1.
“We believe there is significant opportunity to improve the quality of care” at Chestnut Hill, Temple’s CEO Mike Young told bond analysts on Nov. 17, which will lead to better community perception of “a hospital that’s been underperforming for decades.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
